D. Medical expands U.S. distribution for infusion sets

D. Medical Industries (NASDAQ, TASE:DMED) has signed a non-exclusive distribution agreement with Agile Edge Technologies for the distribution of its Spring Universal Infusion Sets in the U.S.

“This marks our third non-exclusive distribution agreement and provides us with important new access to the governmental sector,” D. Medical CEO Efri Argaman said in a statement.

“As we continue to execute our growth strategy, expanding our U.S. distribution network and enhancing our access to additional market segments by partnering with key distributors like Agile Edge will be a key factor in our success.”

The Spring Universal Infusion Set is compatible with most insulin pumps currently on the market. Going beyond the minimum requirements of subcutaneous drug delivery, the Spring Universal offers features such as a hidden, auto-retractable needle, 360-degree connector, and smallest one-click, all-in-one inserter. The core of the device is a proprietary Detach-Detect mechanism in case the base of the infusion set detaches from the user’s body, providing additional safety and peace of mind – especially for athletes and the parents of pediatric patients.

According to the American Diabetes Association, there are some 26 million diabetics in the U.S., of which an estimated 5.4%, or 1.4 million, suffer from Type 1 diabetes and 350,000 currently rely on insulin pump therapy. The annual market for infusion sets alone is estimated to total $730 million in the U.S.